These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7561956

  • 1. Is dystrophin always altered in Becker muscular dystrophy patients?
    Vainzof M, Passos-Bueno MR, Pavanello RC, Zatz M.
    J Neurol Sci; 1995 Jul; 131(1):99-104. PubMed ID: 7561956
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis.
    Nicholson LV, Johnson MA, Bushby KM, Gardner-Medwin D, Curtis A, Ginjaar IB, den Dunnen JT, Welch JL, Butler TJ, Bakker E.
    J Med Genet; 1993 Sep; 30(9):745-51. PubMed ID: 8411069
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Abnormal dystrophin expression in patients with limb girdle syndromes.
    Beyenburg S, Zierz S, Arahata K, Mundegar RR, Friedl W, Jerusalem F.
    J Neurol; 1994 Feb; 241(4):210-7. PubMed ID: 8195819
    [Abstract] [Full Text] [Related]

  • 6. Dystrophin immunostaining in muscles from patients with different types of muscular dystrophy: a Brazilian study.
    Vainzof M, Pavanello RC, Pavanello Filho I, Passos-Bueno MR, Rapaport D, Hsi CT, Zatz M.
    J Neurol Sci; 1990 Sep; 98(2-3):221-33. PubMed ID: 1700808
    [Abstract] [Full Text] [Related]

  • 7. Improved diagnosis of Becker muscular dystrophy by dystrophin testing.
    Hoffman EP, Kunkel LM, Angelini C, Clarke A, Johnson M, Harris JB.
    Neurology; 1989 Aug; 39(8):1011-7. PubMed ID: 2668783
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Distinction of Becker from limb-girdle muscular dystrophy by means of dystrophin cDNA probes.
    Norman A, Thomas N, Coakley J, Harper P.
    Lancet; 1989 Mar 04; 1(8636):466-8. PubMed ID: 2563842
    [Abstract] [Full Text] [Related]

  • 10. Sarcolemmal distribution of abnormal dystrophin in Xp21 carriers.
    Vainzof M, Nicholson LV, Bulman DE, Tsanaclis AM, Passos-Bueno MR, Pavanello RC, Zatz M.
    Neuromuscul Disord; 1993 Mar 04; 3(2):135-40. PubMed ID: 7689380
    [Abstract] [Full Text] [Related]

  • 11. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.
    Nicholson LV, Johnson MA, Bushby KM, Gardner-Medwin D, Curtis A, Ginjaar IB, den Dunnen JT, Welch JL, Butler TJ, Bakker E.
    J Med Genet; 1993 Sep 04; 30(9):737-44. PubMed ID: 8411068
    [Abstract] [Full Text] [Related]

  • 12. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T, Stuettgen P, Cremer M, Goebel HH.
    Neuropediatrics; 1991 Aug 04; 22(3):152-62. PubMed ID: 1944822
    [Abstract] [Full Text] [Related]

  • 13. Deletions in the dystrophin gene: analysis of Duchenne and Becker muscular dystrophy patients in Quebec.
    Simard LR, Gingras F, Delvoye N, Vanasse M, Melançon SB, Labuda D.
    Hum Genet; 1992 Jun 04; 89(4):419-24. PubMed ID: 1618490
    [Abstract] [Full Text] [Related]

  • 14. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
    Lukás Z, Vojtísková M, Fajkusová L, Bednarík J, Kadanka Z, Hájek J, Hermanová M, Vohánka S, Vytopil M.
    Cesk Patol; 2001 Nov 04; 37(4):137-45. PubMed ID: 11813630
    [Abstract] [Full Text] [Related]

  • 15. PCR and immunoblot analyses of dystrophin in Becker muscular dystrophy.
    Uchino M, Miike T, Iwashita H, Uyama E, Yoshioka K, Sugino S, Ando M.
    J Neurol Sci; 1994 Jul 04; 124(2):225-9. PubMed ID: 7964876
    [Abstract] [Full Text] [Related]

  • 16. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy.
    Nicholson LV, Johnson MA, Gardner-Medwin D, Bhattacharya S, Harris JB.
    Acta Neuropathol; 1990 Jul 04; 80(3):239-50. PubMed ID: 2205076
    [Abstract] [Full Text] [Related]

  • 17. The frequency of patients with dystrophin abnormalities in a limb-girdle patient population.
    Arikawa E, Hoffman EP, Kaido M, Nonaka I, Sugita H, Arahata K.
    Neurology; 1991 Sep 04; 41(9):1491-6. PubMed ID: 1842672
    [Abstract] [Full Text] [Related]

  • 18. Is the maintainance of the C-terminus domain of dystrophin enough to ensure a milder Becker muscular dystrophy phenotype?
    Vainzof M, Takata RI, Passos-Bueno MR, Pavanello RC, Zatz M.
    Hum Mol Genet; 1993 Jan 04; 2(1):39-42. PubMed ID: 8490621
    [Abstract] [Full Text] [Related]

  • 19. Dystrophin analysis in the diagnosis of muscular dystrophy.
    Norman AM, Hughes HE, Gardner-Medwin D, Nicholson LV.
    Arch Dis Child; 1989 Oct 04; 64(10):1501-3. PubMed ID: 2684033
    [Abstract] [Full Text] [Related]

  • 20. Linkage analysis in families with autosomal recessive limb-girdle muscular dystrophy (LGMD) and 6q probes flanking the dystrophin-related sequence.
    Passos-Bueno MR, Terwilliger J, Ott J, Vainzof M, Love DR, Davies KE, Zatz M.
    Am J Med Genet; 1991 Jan 04; 38(1):140-6. PubMed ID: 2012126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.